Q Wang, Q Zhou, Z Du, R Lu, Y Jiang, H Zhu - Journal of Affective Disorders, 2024 - Elsevier
Objective Daridorexant, a novel dual orexin receptor antagonist, was approved by the FDA
in 2022 for the treatment of insomnia in adults. The aim of this study is to delve into the …